Asia Pacific Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class; Route of Administration; Application; and Distribution Channel, and Country- Product Image

Sale

Asia Pacific Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class; Route of Administration; Application; and Distribution Channel, and Country

Report
147 Pages
November 2020
Region: Asia Pacific
The Insight Partners
ID: 5231429

UP TO €1448EUR$1,500USD£1,242GBP OFF until Jun 30^th 2024

According to the publisher's new market research study on “Asia Pacific Gastrointestinal Drugs Market to 2027 - Regional Analysis and Forecast - by Drug Class, Route of Administration, Application, and Distribution Channel” the market is expected to reach US$ 13,618.35 million by 2027 from US$ 8,868.44 million in 2019; it is estimated to grow at a CAGR of 5.6% from 2020 to 2027. The report provides trends prevailing in the Asia Pacific gastrointestinal drugs market and the factors driving the market growth along with those hindering it.

In 2019, the acid neutralizers segment accounted for the highest share of the market. However, the biologics segment is expected to be the fastest-growing during the forecast period. The CAGR of the biologics segment has the highest CAGR in the forecast period. The growth of the segment is attributed to growing product development and increasing product launches in the market.

The growth of the Asia Pacific Gastrointestinal Drugs market is mainly attributed to rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics. However, low awareness associated with gastrointestinal disorders in low-income economies will restrict the market growth.

GlaxoSmithKline plc; Celltrion Healthcare Co., Ltd.; Johnson and Johnson Services, Inc.; AstraZeneca; and Takeda Pharmaceutical Company Limited are among the leading companies operating in the Asia Pacific Gastrointestinal Drugs market.

The Report Segments Asia Pacific Gastrointestinal Drugs Market as Follows:

Asia Pacific Gastrointestinal Drugs Market - By Drug Class

Acid Neutralizers
Antidiarrheal and Laxatives
Anti-Inflammatory Drugs
Antiemetic and Antinauseants
Biologics
Others

Asia Pacific Gastrointestinal Drugs Market - By Route of Administration

Oral
Parenteral

Asia Pacific Gastrointestinal Drugs Market - By Application

Inflammatory Ulcerative Colitis
Crohn's Disease
Irritable Bowel Syndrome
Gastroenteritis
Celiac Disease
Others

Asia Pacific Gastrointestinal Drugs Market - By Country

Asia Pacific
Japan
China
India
South Korea
Australia
Rest of APAC

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific gastrointestinal drugs market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Gastrointestinal Drugs Market - by Drug Class
1.3.2 Asia Pacific Gastrointestinal Drugs Market - by Route of Administration
1.3.3 Asia Pacific Gastrointestinal Drugs Market - by Application
1.3.4 Asia Pacific Gastrointestinal drugs Market - by Distribution Channel
1.3.5 Asia Pacific Gastrointestinal drugs Market - by Country

2. Asia Pacific Gastrointestinal Drugs Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Gastrointestinal Drugs Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
4.2.1 Gastrointestinal Drugs Market - Asia Pacific PEST Analysis
4.3 Expert Opinion

5. Asia Pacific Gastrointestinal Drugs Market - Key Market Dynamics

5.1 Key Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal (GI) Diseases
5.1.2 Increase in Development of Biologics
5.2 Market Restraints
5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
5.3 Market Opportunities
5.3.1 Increasing Investment in Research Activities and Growing Pipeline of GI Candidates
5.4 Future Trends
5.4.1 Emergence of Biosimilars
5.5 Impact Analysis

6. Gastrointestinal Drugs Market - Asia Pacific Analysis

6.1 Asia Pacific Gastrointestinal Drugs Market Revenue Forecasts and Analysis

7. Asia Pacific Gastrointestinal Drugs Market Analysis and Forecasts to 2027 - by Drug Class

7.1 Overview
7.2 Asia Pacific Gastrointestinal Drugs Market, by Drug Class 2019 & 2027 (%)
7.2.1 Asia Pacific Gastrointestinal drugs Market Revenue and Forecasts to 2027, by Drug Class (US$ Mn)
7.3 Acid Neutralizers
7.3.1 Overview
7.3.2 Asia Pacific Acid Neutralizers Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Antidiarrheal and Laxatives
7.4.1 Overview
7.4.2 Asia Pacific Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Anti-Inflammatory Drugs
7.5.1 Overview
7.5.2 Asia Pacific Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Antiemetic and Antinauseants
7.6.1 Overview
7.6.2 Asia Pacific Antiemetic and Antinauseants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Biologics
7.7.1 Overview
7.7.2 Asia Pacific Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Others
7.8.1 Overview
7.8.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Asia Pacific Gastrointestinal Drugs Market Analysis - by Route of Administration

8.1 Overview
8.2 Asia Pacific Gastrointestinal Drugs Market, by Route of Administration 2019-2027 (%)
8.2.1 Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Route of Administration (US$ Mn)
8.3 Oral
8.3.1 Overview
8.3.2 Asia Pacific Oral Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Parenteral
8.4.1 Overview
8.4.2 Asia Pacific Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

9. Asia Pacific Gastrointestinal Drugs Market Analysis - by Application

9.1 Overview
9.2 Asia Pacific Gastrointestinal Drugs Market, by Application 2019-2027 (%)
9.2.1 Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Application (US$ Mn)
9.3 Inflammatory Ulcerative Colitis
9.3.1 Overview
9.3.2 Asia Pacific Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Crohn's Disease
9.4.1 Overview
9.4.2 Asia Pacific Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Irritable Bowel Syndrome
9.5.1 Overview
9.5.2 Asia Pacific Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Gastroenteritis
9.6.1 Overview
9.6.2 Asia Pacific Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Celiac Disease
9.7.1 Overview
9.7.2 Asia Pacific Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Asia Pacific Gastrointestinal Drugs Market Analysis - by Distribution Channel

10.1 Overview
10.2 Asia Pacific Gastrointestinal Drugs Market, by Distribution Channel 2019-2027 (%)
10.2.1 Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Distribution Channel (US$ Mn)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 Asia Pacific Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 Asia Pacific Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Online Pharmacies
10.5.1 Overview
10.5.2 Asia Pacific Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

11. Gastrointestinal Drugs Market Revenue and Forecasts to 2027 - Geographical Analysis

11.1 Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027
11.1.1 Overview
11.1.2 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 Asia Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.4 Asia Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.5 Asia Pacific: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.6 Asia Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.7 Asia Pacific: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
11.1.8 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 China: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.8.3 China: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.8.4 China: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.8.5 China: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.9 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Japan: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.9.3 Japan: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.9.4 Japan: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.9.5 Japan: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.10 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 India: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.10.3 India: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.10.4 India: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.10.5 India: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.11 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.1 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.2 South Korea: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.11.3 South Korea: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.11.4 South Korea: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.11.5 South Korea: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.12 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Australia: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.12.3 Australia: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.12.4 Australia: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.12.5 Australia: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.13 Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.13.1 Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.13.2 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.13.3 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.13.4 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.13.5 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)

12. Impact of COVID-19 Pandemic on Asia Pacific Gastrointestinal Drugs Market

12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

13. Company Profiles

13.1 Takeda Pharmaceutical Company Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Celltrion Healthcare Co.,Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 AstraZeneca
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix

14.1 Glossary of Terms

List of Tables

Table 1. Asia Pacific Gastrointestinal drugs Market Revenue and Forecasts to 2027, by Drug Class (US$ Mn)
Table 2. Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Route of Administration (US$ Mn)
Table 3. Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Application (US$ Mn)
Table 4. Asia Pacific Gastrointestinal Drugs Market Revenue and Forecasts to 2027, by Distribution Channel (US$ Mn)
Table 5. Asia Pacific Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 6. Asia Pacific Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. Asia Pacific Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 8. Asia Pacific Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. China Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 10. China Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. China Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 12. China Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. Japan Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 14. Japan Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 15. Japan Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 16. Japan Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. India Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 18. India Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 19. India Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. India Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. South Korea Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 22. South Korea Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 23. South Korea Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 24. South Korea Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 25. Australia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 26. Australia Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 27. Australia Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 28. Australia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 29. Rest of Asia-Pacific Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 30. Rest of Asia-Pacific Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 31. Rest of Asia-Pacific Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 32. Rest of Asia-Pacific Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 33. Glossary of Terms, Gastrointestinal Drugs Market

List of Figures

Figure 1. Gastrointestinal Drugs Market Segmentation
Figure 2. Asia Pacific Gastrointestinal Drugs Market Overview
Figure 3. Acid Neutralizers Segment Held Largest Share of Product in Gastrointestinal Drugs Market
Figure 4. Japan is Expected to show Remarkable Growth during the Forecast Period
Figure 5. Asia Pacific Gastrointestinal Drugs Market - Leading Country Markets (US$ Mn)
Figure 6. Gastrointestinal Drugs Market - Asia Pacific PEST Analysis
Figure 7. Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint
Figure 8. Asia Pacific Gastrointestinal Drugs market - Revenue Forecasts and Analysis-2019-2027
Figure 9. Asia Pacific Gastrointestinal Drugs Market, by Drug Class 2019 & 2027 (%)
Figure 10. Asia Pacific Acid Neutralizers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Antiemetic and Antinauseants Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Biologics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Gastrointestinal Drugs Market, by Route of Administration 2019 & 2027 (%)
Figure 17. Asia Pacific Oral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia Pacific Gastrointestinal Drugs Market, by Application 2019 & 2027 (%)
Figure 20. Asia Pacific Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Asia Pacific Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Asia Pacific Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Asia Pacific Gastrointestinal Drugs Market, by Distribution Channel 2019 & 2027 (%)
Figure 27. Asia Pacific Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Asia Pacific Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Asia Pacific Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Asia Pacific: Gastrointestinal Drugs Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. Asia Pacific Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)
Figure 32. China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 33. Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Asia Pacific Countries

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Johnson and Johnson Services, Inc.
GlaxoSmithKline plc
Celltrion Healthcare Co., Ltd.
AstraZeneca
Takeda Pharmaceutical Company Limited

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2027EUR$2,100USD£1,739GBP €2896EUR$3,000USD£2,484GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2703EUR$2,800USD£2,318GBP €3861EUR$4,000USD£3,312GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3378EUR$3,500USD£2,898GBP €4826EUR$5,000USD£4,140GBP

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Gastrointestinal Therapeutics - Global Strategic Business Report

Global Gastrointestinal Drugs Market by Drug Category (Acid Neutralizers, Anti-Inflammatory, Antiemetic & Antinauseants), Disease Type (Gastroesophageal Reflux Disorder, Irritable Bowel Syndrome), Route of Administration, End User - Forecast 2024-2030

Global Gastrointestinal Drugs Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

Gastrointestinal Therapeutics Market By Drug Class, By Application, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

Gastrointestinal OTC Drugs Market by Drug Class, Indication, End User, and Region 2023-2028